What the Product Label Does Not Tell You About Drug-Drug Interaction Management Time for a Re-Appraisal

Burger, David MM, le Comte, Marianne, Smolders, Elise JJ, Jacobs, Tom GG, ter Heine, Rob, Knibbe, Catherijne AJ and Pirmohamed, Munir ORCID: 0000-0002-7534-7266 (2023) What the Product Label Does Not Tell You About Drug-Drug Interaction Management Time for a Re-Appraisal. JOURNAL OF CLINICAL PHARMACOLOGY, 63 (11). pp. 1181-1185.

Access the full-text of this item by clicking on the Open Access link.

Official URL: http://dx.doi.org/10.1002/jcph.2316

Item Type:	Article
Uncontrolled Keywords:	CYP3A, drug-drug interactions, product information, regulatory approval
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User:	Symplectic Admin
Date Deposited:	02 Oct 2023 09:20
Last Modified:	21 Oct 2023 01:07
DOI:	10.1002/jcph.2316
Open Access URL:	https://doi.org/10.1002/jcph.2316
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3173270